Overactivation of histone deacetylases and EZH2 in Wilms tumorigenesis

Overactivation of histone deacetylases and EZH2 in Wilms tumorigenesis

Bibliographic Details
Main Authors:	Chao-Hui Chen, Nguyen Yen Nhi Ngo, Alun Wang, Samir El-Dahr, Hongbing Liu
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2023-09-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304222002987

Similar Items

Fluid-electrolyte homeostasis requires histone deacetylase function
by: Kelly A. Hyndman, et al.
Published: (2020-08-01)

Histone Deacetylase Inhibitors Antagonize Distinct Pathways to Suppress Tumorigenesis of Embryonal Rhabdomyosarcoma.
by: Terra Vleeshouwer-Neumann, et al.
Published: (2015-01-01)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01)

Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells.
by: Tao Yan-Fang, et al.
Published: (2015-01-01)

EZH2 Inhibition Sensitizes IDH1R132H-Mutant Gliomas to Histone Deacetylase Inhibitor
by: Lisa Sprinzen, et al.
Published: (2024-01-01)

Suppression of enhancer overactivation by a RACK7-Histone demethylase complex
by: Shen, H, et al.
Published: (2016)

Histone deacetylase 6 in cancer
by: Ting Li, et al.
Published: (2018-09-01)

Targeted disruption of the histone lysine 79 methyltransferase Dot1L in nephron progenitors causes congenital renal dysplasia
by: Fenglin Wang, et al.
Published: (2021-11-01)

Histone deacetylase inhibitors
by: Marzena Baran, et al.
Published: (2020-08-01)

Role of Histone Deacetylase 6 and Histone Deacetylase 6 Inhibition in Colorectal Cancer
by: Ana Vuletić, et al.
Published: (2023-12-01)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01)

Histone deacetylase 3, not histone deacetylase 2, interacts with the major immediate early locus of human cytomegalovirus
by: Wang Weijia, et al.
Published: (2011-03-01)

Histone Deacetylase 3 Governs β-Estradiol-ERα-Involved Endometrial Tumorigenesis via Inhibition of STING Transcription
by: Guofang Chen, et al.
Published: (2022-09-01)

Histone Deacetylase Inhibitors Are Protective in Acute but Not in Chronic Models of Ototoxicity
by: Chao-Hui Yang, et al.
Published: (2017-10-01)

The Impact of Fluorination on the Design of Histone Deacetylase Inhibitors
by: Duong Tien Anh, et al.
Published: (2023-02-01)

The application of histone deacetylases inhibitors in glioblastoma
by: Rui Chen, et al.
Published: (2020-07-01)

Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy
by: Xiangyu Ke, et al.
Published: (2021-07-01)

Histone deacetylase 10 structure and molecular function as a polyamine deacetylase
by: Yang Hai, et al.
Published: (2017-05-01)

Dual Inhibitors Targeting DNA and Histone Deacetylases
by: Chen Chen, et al.
Published: (2020-06-01)

The Role and Mechanism of Histone Deacetylases in Acute Kidney Injury
by: Xun Zhou, et al.
Published: (2021-06-01)

Histone deacetylase inhibitors in multiple myeloma
by: Sarah Deleu, et al.
Published: (2009-06-01)

Antidepressant Actions of Histone Deacetylase Inhibitors
by: Haggarty, Stephen J., et al.
Published: (2010)

Histone deacetylase-2 and airway disease
by: Peter J. Barnes
Published: (2009-10-01)

Histone deacetylases and their inhibition in Candida species
by: Cecile Garnaud, et al.
Published: (2016-08-01)

Medicinal chemistry of histone deacetylase inhibitors
by: Ružić Dušan, et al.
Published: (2021-01-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01)

Histone acetylation and the role of histone deacetylases in normal cyclic endometrium
by: Palak Gujral, et al.
Published: (2020-08-01)

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
by: Kim Freese, et al.
Published: (2019-10-01)

Statins and Histone Deacetylase Inhibitors Affect Lamin A/C – Histone Deacetylase 2 Interaction in Human Cells
by: Elisabetta Mattioli, et al.
Published: (2019-01-01)

mTOR Overactivation and Compromised Autophagy in the Pathogenesis of Pulmonary Fibrosis.
by: Yao-Song Gui, et al.
Published: (2015-01-01)

Enhancing the anti-angiogenic action of histone deacetylase inhibitors
by: Dwarte Tanya, et al.
Published: (2007-10-01)

Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases
by: Tingting Li, et al.
Published: (2021-02-01)

Histone deacetylase 3 regulates microglial function through histone deacetylation
by: Laura Meleady, et al.
Published: (2023-12-01)

Targeting Excessive EZH1 and EZH2 Activities for Abnormal Histone Methylation and Transcription Network in Malignant Lymphomas
by: Makoto Yamagishi, et al.
Published: (2019-11-01)

Advanced Progress of Histone Deacetylases in Rheumatic Diseases
by: Liu XM, et al.
Published: (2024-02-01)

Role of Histone Deacetylases in T-Cell Development and Function
by: Monika Pieniawska, et al.
Published: (2022-07-01)

Histone Deacetylase Inhibitors from Marine Invertebrates
by: Claudio Luparello, et al.
Published: (2020-11-01)

Roles of Histone Deacetylases and Inhibitors in Anticancer Therapy
by: Flávia Alves Verza, et al.
Published: (2020-06-01)

Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
by: Ehab Ghazy, et al.
Published: (2022-01-01)

Histone Deacetylases 1 and 2 in Memory Function
by: Pao, Ping-Chieh, et al.
Published: (2023)